lorigerlimab
macrogenics
['prostate', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'imab ']
enjoyed sharing the results #gu23 for lorigerlimab (pd1xctla4 dart) in mcrpc #prostatecancer 20+% psa90 that is durable in unselected &amp; refractory pts w &lt; 8% high-grade irae. data look great &amp; looking forward to next steps as monorx &amp; in combos! #immunotherapy 
Immunotherapy of Cancer • Melanoma • Phase I Clinical Trials • Mastodon: @jasonlukemd@mastodon • Lab: @ImmunoTiil • Disclosures at https://t.co/mcWOaTaiZn…